Charlotte S Larned

Title: The Innovative Contributions of Charlotte S. Larned

Introduction

Charlotte S. Larned is a notable inventor based in Galveston, Texas. She has made significant contributions to the field of medical research, particularly in the treatment of viral infections. Her work focuses on the enhancement of antiviral agents through the use of anti-cachexia agents.

Latest Patents

Charlotte S. Larned holds a patent for the invention titled "Potentiation of tumor necrosis factor (TNF) of interferon B1 (IFN-B1)." This invention discloses the use of an anti-cachexia agent in conjunction with an antiviral agent, which serves as a therapeutic agent in treating viral infections. The anti-cachexia agent is designed to enhance the antiviral activity significantly, potentially increasing its effectiveness by several hundred fold. Additionally, this agent helps to mitigate the anti-proliferative or host-destroying effects of the antiviral agent. The preferred anti-cachexia agent identified in her patent is hydrazine sulfate, while the antiviral agent includes interferon, tumor necrosis factor, or any combination thereof.

Career Highlights

Charlotte S. Larned is affiliated with the University of Texas System, where she continues her research and development efforts. Her work has garnered attention for its innovative approach to enhancing antiviral treatments.

Collaborations

Charlotte has collaborated with Thomas K. Hughes, Jr., contributing to the advancement of her research and the development of her patented inventions.

Conclusion

Charlotte S. Larned's innovative work in the field of antiviral treatments showcases her dedication to improving medical therapies. Her patent reflects a significant advancement in the treatment of viral infections, highlighting her role as a leading inventor in this important area of research.